EX-99.1 2 y12462a1exv99w1.txt JOINT FILING AGREEMENT EXHIBIT 1 Joint Filing Agreement In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the persons named below agrees to the joint filing of a Statement on Schedule 13D (including amendments thereto) with respect to the common stock, par value $0.001 per share, of Idenix Pharmaceuticals, Inc., a Delaware corporation. Date: September 2, 2005 NOVARTIS AG By: /s/ George Miller ---------------------------------- Name: George Miller Title: Authorized Signatory By: /s/ Peter Rupprecht ---------------------------------- Name: Peter Rupprecht Title: Authorized Signatory NOVARTIS PHARMA AG By: /s/ Robert E. Pelzer ---------------------------------- Name: Robert E. Pelzer Title: General Counsel By: /s/ Joseph E. Mamie ---------------------------------- Name: Joseph E. Mamie Title: Head Operational Treasury NOVARTIS BIOVENTURES LTD. By: /s/ Emil Bock ---------------------------------- Name: Emil Bock Title: Member of the Board of Directors Page 12 of 12